top of page


Full Bibliography 

Recent Publications

Zhang Y, Patel RP, Kim KH, Cho H, Jo JC, Jeong SH, Oh SY, Choi YS, Kim SH, Lee JH, Angelos M, Guruprasad P, Cohen I, Ugwuanyi O, Lee YG, Pajarillo R, Cho JH, Carturan A, Paruzzo L, Ghilardi G, Wang M, Kim S, Kim SM, Lee HJ, Park JH, Cui L, Lee TB, Hwang IS, Lee YH, Lee YJ, Porazzi P, Liu D, Lee Y, Kim JH, Lee JS, Yoon DH, Chung J, Ruella M. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study. Mol Cancer. 2023 Dec 9;22(1):200. doi: 10.1186/s12943-023-01886-9. PubMed PMID: 38066564; PubMed Central PMCID: PMC10709913.


Chae J, Choi J, Chung J. Polymeric immunoglobulin receptor (pIgR) in cancer. J Cancer Res Clin Oncol. 2023 Dec;149(19):17683-17690. doi: 10.1007/s00432-023-05335-4. Epub 2023 Oct 28. Review. PubMed PMID: 37897659.


Kim JY, Jeon K, Hong JJ, Park SI, Cho H, Park HJ, Kwak HW, Park HJ, Bang YJ, Lee YS, Bae SH, Kim SH, Hwang KA, Jung DI, Cho SH, Seo SH, Kim G, Oh H, Lee HY, Kim KH, Lim HY, Jeon P, Lee JY, Chung J, Lee SM, Ko HL, Song M, Cho NH, Lee YS, Hong SH, Nam JH. Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV. Sci Rep. 2023 May 20;13(1):8189. doi: 10.1038/s41598-023-35328-9. PubMed PMID: 37210393; PubMed Central PMCID: PMC10199661.


Kang HY, Lee SY, Kim HM, Lee SU, Lee H, Cho MY, Oh SC, Kim SM, Park HS, Han EH, Kim SE, Kim H, Yoon SR, Doh J, Chung J, Hong KS, Choi I, Kim TD. A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets. Front Immunol. 2022;13:1089369. doi: 10.3389/fimmu.2022.1089369. eCollection 2022. PubMed PMID: 36713381; PubMed Central PMCID: PMC9880444.


Park JC, Noh J, Jang S, Kim KH, Choi H, Lee D, Kim J, Chung J, Lee DY, Lee Y, Lee H, Yoo DK, Lee AC, Byun MS, Yi D, Han SH, Kwon S, Mook-Jung I. Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease. Cell Rep. 2022 Sep 20;40(12):111391. doi: 10.1016/j.celrep.2022.111391. PubMed PMID: 36130492.


Lee H, Yoo DK, Han J, Kim KH, Noh J, Lee Y, Lee E, Kwon S, Chung J. Optimization of peripheral blood volume for in silico reconstitution of the human B-cell receptor repertoire. FEBS Open Bio. 2022 Sep;12(9):1634-1643. doi: 10.1002/2211-5463.13467. Epub 2022 Aug 9. PubMed PMID: 35866358; PubMed Central PMCID: PMC9433817.


Lee AC, Lee Y, Choi A, Lee HB, Shin K, Lee H, Kim JY, Ryu HS, Kim HS, Ryu SY, Lee S, Cheun JH, Yoo DK, Lee S, Choi H, Ryu T, Yeom H, Kim N, Noh J, Lee Y, Kim I, Bae S, Kim J, Lee W, Kim O, Jung Y, Kim C, Song SW, Choi Y, Chung J, Kim BG, Han W, Kwon S. Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches. Nat Commun. 2022 May 9;13(1):2540. doi: 10.1038/s41467-022-30299-3. PubMed PMID: 35534484; PubMed Central PMCID: PMC9085828.


Ahn SY, Kim J, Vellampatti S, Oh S, Lim YT, Park SH, Luo D, Chung J, Um SH. Protein-Encoding Free-Standing RNA Hydrogel for Sub-Compartmentalized Translation. Adv Mater. 2022 May;34(18):e2110424. doi: 10.1002/adma.202110424. Epub 2022 Apr 4. PubMed PMID: 35263477.


Lee SK, Han J, Piao H, Shin N, Jang JY, Yan JJ, Kim H, Chung J, Yang J. Anti-C4d chimeric antigen receptor regulatory T cells suppressed allograft rejection in ABO-incompatible heart transplantation. Genes Dis. 2022 Jan;9(1):1-4. doi: 10.1016/j.gendis.2021.07.001. eCollection 2022 Jan. PubMed PMID: 35005103; PubMed Central PMCID: PMC8720693.


Lee SJ, Kim S, Jo DH, Cho CS, Kim SR, Kang D, Chae J, Yoo DK, Ha S, Chung J, Kim JH. Specific ablation of PDGFRβ-overexpressing pericytes with antibody-drug conjugate potently inhibits pathologic ocular neovascularization in mouse models. Commun Med (Lond). 2021;1:58. doi: 10.1038/s43856-021-00059-3. eCollection 2021. PubMed PMID: 35602228; PubMed Central PMCID: PMC9053257.


Lee A, Yoo DK, Lee Y, Jeon S, Jung S, Noh J, Ju S, Hwang S, Kim HH, Kwon S, Chung J, Choi Y. Induction of Anti-Aquaporin 5 Autoantibody Production by Immunization with a Peptide Derived from the Aquaporin of Prevotella melaninogenica Leads to Reduced Salivary Flow in Mice. Immune Netw. 2021 Oct;21(5):e34. doi: 10.4110/in.2021.21.e34. eCollection 2021 Oct. PubMed PMID: 34796038; PubMed Central PMCID: PMC8568913.


Zalles M, Smith N, Saunders D, Guzman M, Lerner M, Fung KM, Babu A, Battiste J, Chung J, Hwang K, Jin J, Towner RA. ELTD1 as a multi-focal target for malignant gliomas: preclinical studies. Neurooncol Adv. 2021 Jan-Dec;3(1):vdab132. doi: 10.1093/noajnl/vdab132. eCollection 2021 Jan-Dec. PubMed PMID: 34704036; PubMed Central PMCID: PMC8541707.


Lee Y, Yoo DK, Noh J, Ju S, Lee E, Lee H, Kwon S, Chung J. Amplification of a minimally biased antibody repertoire for in vitro display using a universal primer-based amplification method. J Immunol Methods. 2021 Sep;496:113089. doi: 10.1016/j.jim.2021.113089. Epub 2021 Jun 26. PubMed PMID: 34181966.


Kim SI, Kim S, Shim JM, Lee HJ, Chang SY, Park S, Min JY, Park WB, Oh MD, Kim S, Chung J. Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody. Biochem Biophys Res Commun. 2021 Mar 19;545:33-39. doi: 10.1016/j.bbrc.2021.01.075. Epub 2021 Jan 31. PubMed PMID: 33535104.


Kim SI, Noh J, Kim S, Choi Y, Yoo DK, Lee Y, Lee H, Jung J, Kang CK, Song KH, Choe PG, Kim HB, Kim ES, Kim NJ, Seong MW, Park WB, Oh MD, Kwon S, Chung J. Stereotypic neutralizing V(H) antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals. Sci Transl Med. 2021 Jan 27;13(578). doi: 10.1126/scitranslmed.abd6990. Epub 2021 Jan 4. PubMed PMID: 33397677; PubMed Central PMCID: PMC7875332.

bottom of page